Black Diamond Therapeutic... (BDTX)
NASDAQ: BDTX
· Real-Time Price · USD
2.65
-0.10 (-3.64%)
At close: Aug 19, 2025, 3:59 PM
2.64
-0.56%
After-hours: Aug 19, 2025, 07:03 PM EDT
-3.64% (1D)
| Bid | 2.6 |
| Market Cap | 151.16M |
| Revenue (ttm) | 70M |
| Net Income (ttm) | 14.44M |
| EPS (ttm) | 0.24 |
| PE Ratio (ttm) | 11.06 |
| Forward PE | -2.61 |
| Analyst | Buy |
| Ask | 2.69 |
| Volume | 633,177 |
| Avg. Volume (20D) | 1,101,848 |
| Open | 2.73 |
| Previous Close | 2.75 |
| Day's Range | 2.62 - 2.75 |
| 52-Week Range | 1.20 - 6.75 |
| Beta | 2.88 |
About BDTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BDTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BDTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
-15.24%
Black Diamond Therapeutics shares are trading lowe...
Unlock content with
Pro Subscription
5 months ago
+2.38%
Black Diamond Therapeutics shares are trading higher after the company announced a global licensing agreement with Servier for BDTX-4933.
